Is BMY or CVS cheaper?

On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and CVS at 44.92.

Which has grown faster, BMY or CVS?

Over the past five years, CVS grew revenue faster — BMY at a 2.52% CAGR versus CVS at 8.52%.

Does BMY or CVS pay a bigger dividend?

BMY yields 4.38% and CVS yields 2.61% based on trailing dividends and the latest price.

Is BMY or CVS more profitable?

BMY runs the higher net margin — BMY at 15.01% versus CVS at 0.72%.

Which has been the better investment, BMY or CVS?

Over the past 10-year, CVS delivered the higher annualized total return — BMY at 1.08% versus CVS at 3.66%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs CVS Health Corporation (CVS)

BMY leads on 12 of 16 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and CVS Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

$116.66B

$57.13Healthcare

CVS

CVS Health Corporation

$130.09B

$101.96Healthcare

Total return — BMY vs CVS

growth of $100 · last 30y

BMY +171.1%CVS +882.3%CVS compounded faster

BMY CVS

BMY vs CVS: by the numbers

•CVS is the larger company ($130.09B vs $116.66B market cap).
•BMY trades at the lower earnings multiple (16.05 vs 44.92 P/E).
•BMY converts more revenue to profit (15.01% vs 0.72% net margin).
•CVS grew revenue faster over the past five years (8.52% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.38% vs 2.61%).

Which is better, BMY or CVS?

Metric tally: BMY 12 · CVS 4

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthCVS(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityBMY(higher ROIC)

Valuation

Metric	BMY	CVS
P/E ratio	16.05●	44.92
Forward P/E	9.31●	12.17
P/S ratio	2.41	0.32●
P/B ratio	5.82	1.68●
PEG ratio	1.71	—
EV / EBITDA	11.03●	17.90
FCF yield	10.20%●	5.67%

Profitability

Metric	BMY	CVS
Gross margin	68.75%●	13.87%
Operating margin	25.67%●	1.46%
Net margin	15.01%●	0.72%
ROE	36.25%●	3.79%
ROIC	13.90%●	4.72%

Dividends

Metric	BMY	CVS
Dividend yield	4.38%●	2.61%
Payout ratio	72.25%	190.00%

Growth (annualized)

Metric	BMY	CVS
Revenue CAGR (5Y)	2.52%	8.52%●
EPS CAGR (5Y)	9.38%●	-23.89%
FCF CAGR (5Y)	-2.50%●	-10.57%
Total return CAGR (5Y)	0.74%	7.06%●

Frequently asked

Which is better, BMY or CVS?: It depends on your goal. value: BMY (lower P/E); growth: CVS (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 12 to 4.
Is BMY or CVS cheaper?: On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and CVS at 44.92.
Which has grown faster, BMY or CVS?: Over the past five years, CVS grew revenue faster — BMY at a 2.52% CAGR versus CVS at 8.52%.
Does BMY or CVS pay a bigger dividend?: BMY yields 4.38% and CVS yields 2.61% based on trailing dividends and the latest price.
Is BMY or CVS more profitable?: BMY runs the higher net margin — BMY at 15.01% versus CVS at 0.72%.
Which has been the better investment, BMY or CVS?: Over the past 10-year, CVS delivered the higher annualized total return — BMY at 1.08% versus CVS at 3.66%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio CVS Health P/E ratio Bristol-Myers Squibb dividend yield CVS Health dividend yield Bristol-Myers Squibb ROE CVS Health ROE Bristol-Myers Squibb operating margin CVS Health operating margin Bristol-Myers Squibb revenue growth CVS Health revenue growth Bristol-Myers Squibb free cash flow CVS Health free cash flow

Bristol-Myers Squibb & CVS Health appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.